← Eichor
Study identifier: NCT06075602 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease

Condition: Coronary Disease · Coronary Artery Disease · Coronary Restenosis  ·  Sponsor: Luzerner Kantonsspital

PhaseN/A
Planned participants5000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of the COMPLEX Registry is to prospectively and retrospectively collect baseline, clinical and procedural data of patients who have undergone PCI or CABG for complex and/ or calcified chronic CAD, irrespective of clinical presentation as well as to prospectively collect data about their clinical outcomes. The outcomes will be compared in different clinical subgroups (e.g. PCI vs. CABG). The impact of current PCI techniques/ devices, but also CABG strategies in different clinical settings and coronary artery lesions on cardiovascular outcomes will be assessed.

This description comes directly from the study's public registry record.

Talk to the study team

Florim Cuculi, MD  ·  +41412052154  ·  florim.cuculi@luks.ch

Matthias Bossard, MD  ·  +41412051477  ·  matthias.bossard@luks.ch

Always discuss trial participation with your own doctor first.

Locations (1)

Lucerne Heart CentreLucerne, Canton of Lucerne, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06075602